Accessibility Menu
PharmaCielo logo

PharmaCielo(OTC) PCLOF

Market Cap$10.98MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-99%
5 Year-95%
1 Year+92%
1 Month-21%
$0.05
+14.29%
+0.01Today
PharmaCielo last closing stock price
MetricPriceDate
Last closeUSD 0.052026-08-07
PharmaCielo stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+26.76%USD 0.042026-07-31
1 month-20.72%USD 0.072026-07-08
3 month+43.37%USD 0.042026-05-08
Year to date+39.7%USD 0.042025-12-30
1 year+92.48%USD 0.032025-08-07
3 year-51.86%USD 0.112023-08-08
5 year-94.95%USD 1.032021-08-06
Since inception-99.26%USD 6.992019-01-28

PharmaCielo Financials at a Glance

Market Cap

$10.98MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$2.54M

Net Income (TTM)

-CA$3.28M

EPS (TTM)

-$0.01

P/E Ratio

-3.85

Dividend

$0.00

Beta (Volatility)

0.69 (Low)

Price

$0.05

Volume

150

Open

$0.05

Previous Close

$0.05

Daily Range

$0.05 - $0.05

52-Week Range

$0.00 - $0.12

Estimated Earnings Date

Oct 13, 2026

PCLOF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About PharmaCielo

PharmaCielo Ltd. operates as a pharmaceutical company. It engages in the processing and supplying all natural, medicinal-grade cannabis oil extracts, and related products to large channel distributors. PharmaCielo's principal and wholly owned subsidiary is PharmaCielo Colombia Holdings S.A.S. The company was founded on July 14, 2014 and is headquartered in Toronto, Canada.

Industry

Pharmaceuticals

CEO

Marc Lustig, MBA

Headquarters

Toronto, ON M5C 1P1, CA

PCLOF Financials

Key Financial Metrics (TTM)

Gross Margin

29.56%

Operating Margin

-127.52%

Net Income Margin

-141.06%

Return on Equity

27.36%

Return on Capital

-117.01%

Return on Assets

-28.47%

Earnings Yield

-25.97%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$10.98MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

211.28M

Volume

150

Avg. Volume

65.46K

Financials (TTM)

Gross Profit

CA$627.96K

Operating Income

-CA$3.42M

EBITDA

-CA$785.43K

Operating Cash Flow

-CA$4.62M

Capital Expenditure

CA$7.12

Free Cash Flow

-CA$4.62M

Cash & ST Invst.

CA$17.56K

Total Debt

CA$19.19M

PharmaCielo Performance Analysis

PharmaCielo annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-12-31CAD 1,142,301-72.0%
20242024-12-31CAD 2,540,069122.4%
20252025-03-31CAD 2,281,423-10.2%
20262026-03-31CAD 1,835,064-19.6%
PharmaCielo sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-58.9%
Q32025-09-30175.4%
Q42025-12-31-31.9%
Q12026-03-3118.9%
PharmaCielo annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-12-31CAD -0.082.0%
20242024-12-31CAD -0.04-48.3%
20252025-03-31CAD -0.0520.3%
20262026-03-31CAD -0.01-70.8%
PharmaCielo sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3043.3%
Q32025-09-30-45.1%
Q42025-12-31129.7%
Q12026-03-31-400.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

CA$720.37K

-8.2%

Gross Profit

CA$112.44K

-4.3%

Gross Margin

15.61%

N/A

Market Cap

$10.98MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$40.97K

N/A

Employees

268

N/A

Net Income

-CA$1.30M

+34.9%

EBITDA

-CA$498.48K

+50.2%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

CA$17.56K

-67.2%

Total Debt

CA$19.19M

-12.8%

Accounts Receivable

CA$891.89K

-5.9%

Inventory

CA$1.97M

+45.8%

Long Term Debt

CA$0.00

-100.0%

Short Term Debt

CA$19.19M

+10.1%

Return on Assets

-28.47%

N/A

Return on Invested Capital

29.45%

N/A

Free Cash Flow

-CA$3.74M

-3831.9%

Operating Cash Flow

-CA$3.74M

-3831.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BBRRFBlueberries Medical Corp.
$0.01+32.38%
AVTBFAvant Brands Inc.
$0.41+0.84%
CPIVFCaptiva Verde Wellness Corp.
$0.02+0.00%
BUDZWEED, Inc.
$0.03+50.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$133.11+0.16%
TTDThe Trade Desk
$13.80-0.22%
NVDANvidia
$223.96+0.02%
TLTiShares Trust - iShares 20+ Year Treasury Bond ETF
$82.76+0.00%

Questions About PCLOF

What is the current price of PharmaCielo?

PharmaCielo is trading at $0.05 per share.

What is the 52-week range for PharmaCielo?

Over the past 52 weeks, PharmaCielo has traded between $0.00 and $0.12.

How much debt does PharmaCielo have?

As of the most recent reporting period, PharmaCielo reported total debt of CA$13.71M.

How much cash does PharmaCielo have on hand?

PharmaCielo reported CA$12.55K in cash and cash equivalents in its most recent financial results.

What is PharmaCielo’s dividend yield?

PharmaCielo does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.